Download Your Complimentary Copy of the Agenda
The 11th Microbiome Movement USA Summit equips directors, senior leaders and technical scientists with practical strategies to align clinical, CMC and commercial priorities, advancing translatable LBP and FMT development.
Attending alongside your colleagues allows you to optimize your experience. Download the full event guide below to learn more.
60:40 Split
Strategic & Technical Sessions
60%
Director+ Level Microbiome Speakers
8
Hours of Meaningful Networking Opportunities
>20%
Investor Level Speaker Faculty
11
Years of Bringing the Microbiome Space Together
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Session Spotlight
Here are some hand-picked sessions from our agenda that cater best to your seniority, helping you maximize the value gained from the meeting.
Session Spotlight: Director Level+
Workshop A: Demonstrating Credible Microbiome Mechanistic & Early Clinical Evidence to Engage Pharma Partnerships Earlier
- Benjamin Hadida, Co-Founder & Chief Executive Officer, Exeliom Biosciences
- Henry Haiser, Operating Partner, Corundum Systems Biology
- Ken Blount, Senior Vice President, Head of Microbiome Clinical & Product Development, Ferring Pharmaceuticals
Session Spotlight: Director Level+
Panel Discussion: Sharing Regulatory Navigation Strategies Across Global Agencies to Reduce Uncertainty & Accelerate Clinical Progression
- Paul Carson, Principal Investigator, US Food & Drug Administration (FDA)
- Bharat Dixit, Chief Technology Officer, Adiso Therapeutics
- Kingyin Lee, Head of Clinical Trials, MHRA
Session Spotlight: Scientists
Workshop B: Validating Novel Assay Technologies to Demonstrate Identity Potency & Viability for Regulatory Confidence in Microbiome-Based Therapies
- Philip Burnham, Chief Scientific Officer, Kanvas Biosciences
- Jason Goldsmith, Senior Director, Microbiome Sciences, Nestle Health Science
- Leslie Wagner, Regulatory Specialist, US Food & Drug Administration (FDA)
